Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-04-16 @ 3:50 PM
Study NCT ID:
NCT06277050
Status:
RECRUITING
Last Update Posted:
2024-04-30
First Post:
2024-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Sponsor:
Jiangxi Provincial Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NPC-ICMB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None